Navidea Biopharmaceutica (Israel) Backtesting

NAVB -- Israel Stock  

ILS 73.10  4.90  6.28%

With this equity back-testing module your can estimate the performance of a buy and hold strategy of Navidea Biopharmaceuticals and determine expected loss or profit from investing in Navidea Biopharmaceutica over given investment horizon. Please see also Stocks Correlation.
Horizon     30 Days    Login   to change
SymbolX
Backtest

Search Suggestions

NQETRETNASDAQ ETRE Composite REIT TotIndex
NQETRRTNASDAQ ETRE Residential REIT TIndex
AMFAXNatixis ASG Managed Futures StFund
NCNACCO IndustriesStock
NHNantHealthStock
NKNantKwestStock
NMNavios Maritime HoldingsStock
GESPYNASDAQ OMX Alpha GE vs SPYIndex
GCGRXNationwide Growth CFund
AMFNXNatixis ASG Managed Futures StFund
GCFRXNationwide Inv Dest Cnsrv RFund

Did you try this?

Run Portfolio Optimization Now

   

Portfolio Optimization

Compute new portfolio that will generate highest expected return given your specified tolerance for risk
All  Next Launch Portfolio Optimization

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please see also Stocks Correlation. Please also try Pattern Recognition module to use different pattern recognition models to time the market across multiple global exchanges.
Search macroaxis.com